ERBB2 and cancer: Growth factor treatment further increased the hMena11a phosphorylation in HER2 overexpressing cancer cells, suggesting that stroma mediated paracrine mechanisms not only induce hMena overexpression, but also sustain the phosphorylation of hMena11a.